Updated Jul 16, 2026
PICKERING GRANT has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $13.13M.
Grant Pickering is the Chief Executive Officer and a Director at Vaxcyte, Inc., a clinical-stage vaccine innovation company. He has held various roles in the biotechnology sector, contributing to the development of vaccines aimed at combating bacterial diseases.
| Role | CHIEF EXECUTIVE OFFICER, Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 191 | $56.27 | $11K |
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 602 | $55.30 | $33K |
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 207 | $54.22 | $11K |
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 332 | $55.99 | $19K |
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 356 | $55.23 | $20K |
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 312 | $54.34 | $17K |
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 6.4K | $56.12 | $360K |
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 9.1K | $55.27 | $505K |
| 2026-06-26 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 6.7K | $54.27 | $363K |
| 2026-06-19 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 1.0K | $52.50 | $52K |
| 2026-06-19 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 1.0K | $52.50 | $52K |
| 2026-06-19 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 22.2K | $52.50 | $1.17M |
| 2026-06-19 | PCVX | Vaxcyte, Inc. | S — Open-market sale | 225 | $52.51 | $12K |
| 2026-06-19 | PCVX | Vaxcyte, Inc. | M — Option exercise | 225 | $1.79 | $403 |
| 2026-03-11 | PCVX | Vaxcyte, Inc. | F — Tax withholding / forfeiture | 3.7K | $59.32 | $219K |
| 2026-03-03 | PCVX | Vaxcyte, Inc. | F — Tax withholding / forfeiture | 2.5K | $61.98 | $157K |
| 2026-03-03 | PCVX | Vaxcyte, Inc. | F — Tax withholding / forfeiture | 2.9K | $61.98 | $177K |
| 2026-03-03 | PCVX | Vaxcyte, Inc. | A — Grant or award | 105.1K | $0.00 | |
| 2026-01-16 | PCVX | Vaxcyte, Inc. | G — Bona-fide gift | 100.0K | $0.00 | |
| 2025-09-08 | PCVX | Vaxcyte, Inc. | F — Tax withholding / forfeiture | 7.4K | $32.41 | $238K |
Grant Pickering is the Chief Executive Officer and a Director at Vaxcyte, Inc., a clinical-stage vaccine innovation company. He has held various roles in the biotechnology sector, contributing to the development of vaccines aimed at combating bacterial diseases.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 48 open-market sales ($13.13M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PICKERING GRANT profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.